跳至主要内容
临床试验/NCT02337699
NCT02337699终止不适用

DORSAL ROOT GANGLION STIMULATION AS TREATMENT FOR POSTSURGICAL GROIN PAIN (GASPA Study)

Abbott Medical Devices1 个研究点 分布在 1 个国家目标入组 1 人开始时间: 2015年1月最近更新:
适应症

试验速览

阶段
不适用
状态
终止
入组人数
1
试验地点
1
主要终点
Feasibility Study: To determine subject acceptance of the described QST methodology and protocol; assessed using a 5 point Likert scale

研究概览

简要总结

25-SMI-2014 is a post market observational, questionnaire based study to assess the effectiveness of the Axium neurostimulator as a treatment for chronic post surgical groin pain. Within is also a nested feasibility study to assess the clinical utility of a Quantitive Sensory Testing (QST) protocol in the management of the described study group.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 18 Years(Adult)
性别
Male
接受健康志愿者

入选标准

  • Age between >18 and <65 years
  • Unilateral post surgical groin pain for >6 months
  • Pain localized to the region defined by the anterior superior iliac spine (ASIS), the pubic tubercle, and the groin-gluteal-greater trochanter triangles (3G) point,
  • Pain has no surgical indication
  • Subjects meet the criteria for SCS implantation as set out in the Dutch Neuromodulation Society Guideline
  • Pain characterized by neuropathy and/or allodynia
  • Average daily baseline pain intensity baseline VAS greater than or equal to 50 mm on a 100mm VAS scale
  • Patient willing and able to give informed consent and to participate in observational study

排除标准

  • Inability to speak/read Dutch
  • Bilateral and/or recurrent hernia.
  • Radiofrequency or injection therapy at or close to a target DRG in the 90 days prior to enrolment
  • Current illicit drug use and/or alcohol dependence
  • Active infection, or conditions or indwelling devices that pose an increased risk of infection
  • Active implantable device including implantable cardiac defibrillator, pacemaker, spinal cord stimulator or intrathecal drug pump
  • Participation in another clinical study during the study period.
  • Any other disorder, condition, or circumstance that, in the opinion of the principal investigator, represents a risk to successful completion of all study activities.
  • Additional Criteria for nested feasibility study
  • Additional Inclusion Criteria
  • Participation in the observational study
  • Sign off for sub-study on patient informed consent
  • Additional Exclusion Criteria
  • For sub-study participation only: pain conditions [aside from the post surgical groin pain to be treated], extensive scar tissue, skin conditions, or sensorimotor abnormalities in the areas for QST assessments: the painful groin, the contralateral groin, the ipsilateral arm, and the contralateral hand

结局指标

主要结局

Feasibility Study: To determine subject acceptance of the described QST methodology and protocol; assessed using a 5 point Likert scale

时间窗: Baseline then Post implantation at; 1, 3 and 6 months

Main Study: Pain Relief - Assessed be Change in Pain Intensity from Pre-Treatment Baseline

时间窗: Post implantation at; 1, 3 and 6 months

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验